Amgen "buy," target price raised

09.07.08 - Deutsche Securities

NEW YORK, July 9 (newratings.com) - Analysts at Deutsche Bank Securities maintain their "buy" rating on Amgen Inc (AMGN). The target price has been raised from $52 to $54.

In a research note published yesterday, the analysts mention that despite the significant rise in the company?s share price in the past few weeks, there is additional upside potential. This potential upside is supported by the upcoming d-mab data and attractive valuation of Amgen?s stock, the analysts add.